Juergen Rech, MD

University Clinic Erlangen
Erlangen, Germany

2010 Board certification for Rheumatology (Bavaria, Munich)
2007 Board certification for Internal Medicine (Bavaria, Munich)
1999


1997-1999 Graduation as Medical Doctor (Department of Internal Medicine III, Hematology / Oncology, Immunology / Rheumatology, Friedrich-Alexander University Erlangen-Nuremberg, Germany)
AiP (doctor in practice according to german law at that time) (Department of Internal Medicine III, Hematology / Oncology, Immunology / Rheumatology, Friedrich-Alexander University Clinic Erlangen-Nuremberg, Germany)

Disclosure information not submitted.

Presentation(s):

• 0530: Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study)

  Saturday, November 12, 2022
  4:30 PM – 4:40 PM Eastern Time